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Abstract
The circadian timing system controls daily rhythms of physiology and behavior, and disruption of clock function can trigger
stressful life events. Daily exposure to cigarette smoke (CS) can lead to alteration in diverse biological and physiological
processes. Smoking is associated with mood disorders, including depression and anxiety. Patients with chronic obstructive
pulmonary disease (COPD) have abnormal circadian rhythms, reflected by daily changes in respiratory symptoms and lung
function. Corticosterone (CORT) is an adrenal steroid that plays a considerable role in stress and anti-inflammatory
responses. Serotonin (5-hydroxytryptamine; 5HT) is a neurohormone, which plays a role in sleep/wake regulation and
affective disorders. Secretion of stress hormones (CORT and 5HT) is under the control of the circadian clock in the
suprachiasmatic nucleus. Since smoking is a contributing factor in the development of COPD, we hypothesize that CS can
affect circadian rhythms of CORT and 5HT secretion leading to sleep and mood disorders in smokers and patients with
COPD. We measured the daily rhythms of plasma CORT and 5HT in mice following acute (3 d), sub-chronic (10 d) or chronic
(6 mo) CS exposure and in plasma from non-smokers, smokers and patients with COPD. Acute and chronic CS exposure
affected both the timing (peak phase) and amplitude of the daily rhythm of plasma CORT and 5HT in mice. Acute CS
appeared to have subtle time-dependent effects on CORT levels but more pronounced effects on 5HT. As compared with
CORT, plasma 5HT was slightly elevated in smokers but was reduced in patients with COPD. Thus, the effects of CS on
plasma 5HT were consistent between mice and patients with COPD. Together, these data reveal a significant impact of CS
exposure on rhythms of stress hormone secretion and subsequent detrimental effects on cognitive function, depression-like
behavior, mood/anxiety and sleep quality in smokers and patients with COPD.
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Introduction
Chronic obstructive pulmonary disease (COPD) is the fourth
most common cause of death in the developed world, and cigarette
smoke (CS) is the major risk factor [1,2]. COPD is a disabling
condition associated with progressive breathlessness and a severe
decline in lung function [3]. As COPD progresses, patients
develop more frequent and severe exacerbation induced by
infections, cigarette smoke and air pollutants, with an increased
rate of emergency room visits and hospitalization, mostly at night
and in the early morning hours [4–6]. In healthy individuals,
pulmonary function exhibits a daily rhythm with a noon
maximum (12:00 h) and an early morning minimum (04:00 h).
The early morning rise in lung function is accompanied with
exacerbations of COPD in susceptible individuals [6]. More
pronounced nightly drops in forced vital capacity (FVC), forced
expiratory volume in one second (FEV1) and peak expiratory flow
(PEF) are found in smokers than in non-smokers [7]. This response
may be due to CS-mediated effects on daily rhythms of stress
hormone release, surfactant protein expression, mucus retention/
secretion, and lung inflammation that further amplifies the daily
rhythm in lung function [6,8,9]. Nevertheless, the underlying
molecular mechanisms for CS-induced circadian abnormalities are
not fully understood.
Sleep abnormalities including symptoms of insomnia, excessive
daytime sleepiness, and nocturnal oxygen desaturation are
common in patients with COPD [10–12]. Disrupted sleep in
patients with COPD correlates with respiratory symptoms (cough,
sputum production, wheezing), nocturnal oxygen desaturation,
hypercapnia, and daily changes in airway caliber and resistance
[13]. In addition to primary deficits in lung function and sleep
quality; studies reveal an increased rate of depression and anxiety
among patients with COPD [14,15]. Smoking itself is highly
associated with various neuropsychiatric disorders [16], and
depression often lasts even after smoking cessation [17]. This
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suggests that neurophysiological function is disrupted in a time-
dependent manner in response to CS and in patients with COPD.
Serotonin (5-hydroxytryptamine; 5HT) is a potent neurotrans-
mitter whose levels in the central nervous system are closely
associated with mood disorders including depression [18].
Circulating 5HT is derived from both entero-chromaffin cells in
the gut, pulmonary neuroendocrine cells and neurons of the
Raphe nuclei of the brain [19]. Altered 5HT levels are associated
with both CS-related diseases and depression [20,21]. Genome-
wide analyses reveal that 5HT receptor 4 loci, a member of the
larger 5HT receptor family is associated with regulation of
pulmonary function [22]. Moreover, the level of 5-hydroxyindo-
leacetic acid (5-HIAA), a primary metabolite of 5HT, is known to
correlate with severity of depressive mood disorder in COPD
patients [23,24].
Corticosterone (CORT) is an adrenal steroid and a major
component of the stress response [18]. It has been reported that
increased steroid hormone levels (including CORT) are associated
with both passive and active smoking [25]. In rats, plasma CORT
levels are elevated after smoke exposure [26]. Further, nicotine,
one of the chemical components of tobacco smoke, can stimulate
CORT secretion in mice [27]. In addition, CORT can affect
depression-like behavior in rats [28]. Secretion of both 5HT and
CORT is under direct and indirect control of the circadian clock
in the suprachiasmatic nucleus (SCN). Numerous studies confirm
circadian rhythms of circulating CORT through the temporal
control of the hypothalamic-pituitary-adrenal (HPA) axis by the
SCN [29–33]. The interaction between the circadian timing
system and serotonergic signaling in the brain is also well
established [18,34,35]. The amplitude and timing of both CORT
and 5HT secretion are altered by stress, and these effects are
associated with anxiety and depression, maladies commonly
observed in patients with COPD [17,18,30,36–38].
Cigarette smoking is a contributing factor in the development of
COPD, and smoking may cause rhythmic changes in both CORT
and 5HT levels [1,25]. However, it remains to be determined if
smoking and COPD alter circadian rhythms of CORT and 5HT
secretion. Here, we measured daily rhythms of plasma CORT and
5HT in mice following acute (3 d), sub-chronic (10 d) and chronic
(6 mo) CS exposures. Our aim was to determine if smoking
changes the amplitude or timing of these hormones, and to relate
these effects to the pathophysiology of COPD. To ascertain the
relationship between smoking, COPD and hormone secretory
rhythms, we have also quantified plasma CORT and 5HT levels
in non-smokers, smokers and patients with COPD.
Materials and Methods
Ethics statements
All experimental protocols were performed in accordance with
the standards established by the United States Animal Welfare
Act, as set forth by the National Institutes of Health guidelines.
The research protocol for these studies was approved by the
University of Rochester Committee on Animal Research (UCAR).
Subjects/patients recruitment and the study described here
were approved by the ethical institutional review board (IRB)/
RSRB committee of the University of Rochester Medical Center
(#RSRB00028789). All subjects/patients gave their written
informed consent.
Animals
Male C57BL/6J mice purchased from the Jackson Laboratory
(Bar Harbor, ME) were housed under a 12:12 light-dark (LD)
cycle with lights on at 6 am, and provided regular chow and water
ad lib. For sub-chronic (10 days) CS exposure, mice were entrained
for a minimum of 2 weeks to an inverted 12:12 L:D cycle (lights on
6 pm–6 am) prior to CS exposure. For acute (3 days) and chronic
(6 mo) CS exposures, mice were housed in a standard 12:12 L:D
cycle with lights on from 6 am–6 pm throughout the experiment.
Cigarette smoke exposure
Eight week-old mice were used for CS exposure as described
previously [39]. We used acute (3 d) or sub-chronic (10 d; [which
both induce lung inflammatory responses]) and chronic (6 mo.)
[which causes pulmonary emphysema] CS exposure models to
determine the effect of acute inflammatory responses and
emphysema on daily rhythms of 5HT and CORT secretion.
Mice in the 3 d (acute) model were exposed to CS using a
Baumgartner-Jaeger CSM2082i cigarette smoking machine (CH
Technologies, Westwood, NJ). Mice in the sub-chronic (10 d) and
chronic (6 mo.) models were exposed to CS using a Teague TE-10
smoking machine (Teague Enterprises, Davis, CA). All exposures
were carried out in the Inhalation Facility at the University of
Rochester Medical Center. For acute CS exposure (3 d), mice
were placed in individual compartments of a wire cage, which was
then placed inside a closed plastic box connected to the smoke
source. The smoke was generated from 3R4F research cigarettes
containing 11.0 mg of total particulate matter (TPM), 9.4 mg of
tar and 0.73 mg of nicotine per cigarette (University of Kentucky,
Lexington, KY). The total particulate matter (TPM) in per cubic
meter of air in exposure chamber was monitored in real-time with
a MicroDust Pro-aerosol monitor (Casella CEL, Bedford, UK),
and verified daily by gravimetric sampling [40]. The smoke
concentration was set at a value of ,300 mg/m3 TPM by
adjusting the flow rate of the diluted medical air, and the level of
carbon monoxide in the chamber was 350 ppm [40]. Mice
received two 1 h exposures per day (1 h apart), daily for the
duration of treatment according to the Federal Trade Commission
protocol (1 puff/min of 2 second duration and 35 ml volume) and
were sacrificed at 24 h post-last exposure [41]. Control mice were
exposed to filtered air in an identical chamber according to the
same protocol described for CS exposure. For sub-chronic (10 d)
and chronic (6 mo) CS exposures, 3R4F cigarettes were used to
generate a mixture of sidestream smoke (89%) and mainstream
smoke (11%) at a concentration of ,100 mg/m3 TPM, so as to
avoid the possible toxicity to mice at a high concentration of long-
term CS exposure [42]. Each smoldering cigarette was puffed for 2
seconds, once every minute for a total of 5 puffs, at a flow rate of
1.05 L/min, to provide a standard puff of 35 cm3. Mice received
5 h exposures per day, 5 days/week for consecutive 10 d/6
month, and were sacrificed at 6 h interval after 24 h post-last CS
exposure as described previously [39].
Collection of human samples (non-smokers, smokers,
and patients with COPD)
The clinical characteristics of the patients included in the study
are presented in Table 1. Blood samples (50–100 ml) were taken
from non-smokers, smokers, and patients with COPD as described
earlier [43] in between 8 am–2 pm. Plasma was obtained by
centrifugation (2506g) of lithium-heparinized blood, and assayed
for serotonin and corticosterone as described below.
Measurements of plasma corticosterone (CORT) and
serotonin (5HT) levels
Blood was collected by cardiac puncture. To perform cardiac
puncture, mice were anesthetized by sodium pentobarbital
(50 mg/kg, intraperitoneally), then the right ventricle was accessed
Tobacco Smoke and COPD Alter Hormone Rhythms
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with a 23 gauge needle and 400–500 ml blood was aspirated into a
heparin-coated 3 ml syringe. Blood was immediately collected into
a 2 ml tube and centrifuged for plasma collection. Plasma was
stored at 280uC until further analysis. Plasma corticosterone and
serotonin levels were measured using commercially available
enzyme-linked immunoassay (EIA) kits (Enzo Life Sciences,
Plymouth Meeting, USA) according to the manufacturer’s
instructions.
Results
CS exposure differentially affects daily rhythms of plasma
CORT and 5HT
It has been shown that plasma serotonin and cortisol levels are
directly associated with depression and decreased locomotor
activity [17,18,24,36–38,44], and may also be associated with
depression in smokers and patients with COPD [45–49]. We have
recently reported that acute (3 d), sub-chronic (10 d) and chronic
(6 mo) CS exposures resulted in a significant decline in the level of
locomotor activity and altered the timing of the circadian clock in
brain and lung tissues [39]. The effects of CS on nighttime activity
were particularly robust and suggest the development of ‘‘depres-
sion-like’’ behavior in mice following CS exposure [39]. Here we
determined whether our previously reported effects of CS on
locomotor activity and molecular clock function [39] correlate
with altered levels of circulating 5HT and CORT. As expected, we
observed a peak of plasma CORT near lights off (ZT 9.2063.07)
in mice exposed to clean air (controls; Fig 1A, open symbols and
Table 2). Following acute CS exposure, we observed an apparent
advance of this diurnal pattern of plasma CORT secretion such
that the peak occurred at ZT4.1363.41. The pattern was also
marked by a decline in plasma CORT at ZT12 and a subsequent
rebound of plasma CORT during the middle of the dark phase
(ZT18; Fig. 1A). We next determined the effects of acute CS
exposure on plasma 5HT levels in mice. In air-exposed mice, we
detected a diurnal rhythm of plasma 5HT marked by a rise to
peak levels (Mean 6 SD) from ZT0 to ZT7.0062.26 followed a
return to basal levels by lights off (ZT12; Fig. 1B). This peak of
plasma 5HT was attenuated following CS exposure (Air vs. CS at
ZT6 p,0.05). Further, the peak of plasma 5HT was also
advanced by CS exposure (CS, ZT5.0363.19 vs. Air,
ZT7.062.26). Together, these data suggest that 3 days of CS
exposure affects both the timing (peak phase) and amplitude of the
daily rhythm of plasma CORT and 5HT in mice. Further, acute
CS had subtle phasic effects on the level of plasma CORT, but
more pronounced time-dependent effects were seen in plasma
5HT levels.
Effects of sub-chronic (10 day) CS exposure on daily
rhythms of plasma CORT and 5HT
Given the modest effects of acute CS, we labored to examine
the effects of an additional week of CS exposure on plasma CORT
and 5HT rhythms. This time frame matches that of our previous
study which revealed a significant effect of CS on the level of
locomotor activity in mice [39]. As described in methods, mice
received 5 h of exposure every day for 10 days. One day after the
last exposure, mice were sacrificed beginning at ZT12 every 6 h
for 48 h and plasma was collected. As in the 3 d exposure group,
we detected a diurnal rhythm of plasma CORT in mice exposed
to air for 10 d with a peak at ZT12.0962.64 (Fig. 2A and Table 2).
CS exposed mice had slightly greater plasma CORT levels across
the sampling period though a statistically significant difference was
only detected at ZT12 on the second day of sampling (Fig. 2A).
Sub-chronic CS did not have any effect on the timing of CORT
secretion, as the peak in CS plasma was not significantly different
from sub-chronic air-exposed mice (air ZT12.0962.64 vs. CS
ZT12.2362.75; see Table 2).
Overall, 10 d of sub-chronic CS exposure had little effect on
plasma levels of 5HT across the 48h-sampling period, with the
exception being a considerable increase at ZT6 on the first day of
sampling (Fig. 2B). This peak coincides with the approximate time
of CS exposure in mice, suggesting a transient after-effect of CS
exposure on plasma 5HT. CS did appear to produce a modest
phase advance of the rhythm of plasma 5HT such that the peak
occurred earlier in CS-exposed mice (ZT8.5762.64) when
compared with air-exposed controls (ZT13.5763.55; see Table 2).
Effects of chronic (6 month) CS exposure on daily
rhythms of plasma CORT and 5HT
Our recent data from acute and sub-chronic CS exposure
experiments suggest that CS-induced inflammation is associated
with a considerable decline in activity [39], but only modest
changes in both the timing and amplitude of CORT and 5HT
secretion. Therefore, we sought to determine the timing and
amplitude of CORT and 5HT secretion by chronic CS exposure
(which leads to the development of COPD/emphysema). As
compared to both the acute and sub-chronic air-exposed mice, we
detected a robust diurnal rhythm of plasma CORT in chronic air-
exposed mice marked by a peak at ZT19.0663.23 (Fig. 3A and
see Table 2). Chronic CS-exposure delayed the peak of CORT
Table 1. General clinical characteristics of non-smokers, smokers and COPD patients.
Parameters Non-smokers Smokers COPD
Number of subjects 12 12 11
M:F ratio 6:6 6:6 6:5
Male/Female (%) (50%/50%) (50%/50%) (45%/55%)
Age, yr 61(49–74) 58.8(45–79) 64.1(51–73)
Smoking, pack years - 38.1(9–70) 52.9(8–120)
Smoking status (Current/Ex-smokers) - Current smokers (8) Current smokers (5)
- Ex-smokers (4) Ex-smokers (6)
FEV1 % predicted 105 (89–128) 92 (72–126) 53 (38–104)
ICS; n (%) - n = 1 (8.3%) n= 6 (54.5%)
M:F: Male to Female ratio; FEV1: Forced Expiratory Volume in one second; ICS: inhaled corticosteroids.
doi:10.1371/journal.pone.0087999.t001
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secretion (ZT1.3763.37) and produced phase-specific effects on
the overall level of plasma CORT (Fig. 3A).
As in the other air-exposed groups, we detected a diurnal
rhythm of plasma 5HT in chronic air-exposed mice with a peak at
during the light phase (ZT1.3363.20; Fig. 3B and see Table 2).
However, it is notable that this peak occurred later in younger
mice (3 d and 10 d CS exposure peaks at ZT7 and ZT13.4,
respectively). Plasma 5HT levels declined across the remainder of
the day only to rise again at ZT24 (Fig. 3B). In CS-exposed mice,
plasma 5HT levels were elevated relative to air-exposed controls
throughout the dark phase (ZT12 and ZT18) but dropped
precipitously by the following morning (ZT24). Further, CS
appeared to phase delay the timing of peak plasma 5HT levels
(Fig. 3B). In air-exposed mice, plasma 5HT peaked near ZT6
while CS exposed mice showed a peak closet to ZT20 (Fig. 3B).
Putative effects of aging on daily rhythms of plasma
CORT and 5HT in mice
Given the apparent age-dependent effects on plasma CORT
and 5HT rhythms observed in the chronic CS-exposed group, we
examined the effects of CS as a function of age/treatment duration
across the 24 h day. Our acute and sub-chronic groups were both
approximately 2–4 months old at the time of the experiments,
whereas our chronic exposure groups were closer to 9–12 months
old at the time of euthanasia. As seen in figure 4, CS increased the
level of plasma CORT at ZT0 regardless of treatment duration or
age, though this effect was most pronounced in the 10 d and
chronic CS-exposed groups (Fig. 4A). There was no apparent
effect of treatment duration/age on the level of plasma CORT at
ZT6 (Fig. 4B). At ZT12 there was a tendency for an increase in
CORT levels as a function of age in both the air- and CS-exposed
groups (Fig. 4A–B). These data suggest an age-dependent increase
in the peak level of CORT in mice. This effect of age was not
apparent in the plasma collected at ZT18 (Fig. 4B). Regardless of
treatment (CS vs. air), age (3 d, 10 d or 6 mo), or treatment
duration plasma 5HT levels were significantly greater in the 10 d
and chronic CS-exposed groups (Fig. 5A). Further, there was a
tendency for slightly greater plasma 5HT at both ZT12 and ZT18
in the chronic CS-exposed mice (Fig. 5B).
Plasma levels of CORT and 5HT in non-smokers, smokers,
and patients with COPD
CS can affect physiological rhythms outside the lungs, including
rhythmic hormone secretion, and it is not known whether these
effects of CS also contribute to the pathophysiology of COPD.
Furthermore, since we detected a significant effect of both acute
and chronic CS exposure on daily rhythms of plasma CORT and
5HT in mice, we next determined the plasma levels of each
hormone in non-smokers, smokers (current/ex-smokers), and
COPD patients at approximately the same age (Table 1). Our
goal was to determine whether cigarette smoke and COPD have
any effect on the secretion of these two stress hormones in humans.
We found that the plasma levels of CORT were elevated in
smokers when compared with non-smokers (Fig. 6A). These data
corroborate with our findings in sub-chronic CS (10 d) exposed
mice, wherein CORT levels were increased throughout the 24 h
Figure 1. Daily rhythms of plasma CORT and 5HT in mice exposed to acute (3 day) air or CS. Mice were exposed to acute CS during the
light phase for 3 days, and plasma samples were collected at every 6-h interval (ZT0, ZT6, ZT12, and ZT18) beginning 24 h after the last exposure.
Plasma levels of (A) CORT and (B) 5HT were determined by ELISA. Gray shading indicates the subjective dark phase (ZT12 to ZT24). Data were fit with
non-linear regression (multi-order polynomial) analyses. Data are shown as mean 6 SEM (n= 3–7 mice per group). **P,0.01 significant compared to
CS-exposed mice at ZT6.
doi:10.1371/journal.pone.0087999.g001
Table 2. Center of gravity (COG) values for plasma concentration of CORT and 5HT as determined by CircWave analysis in 3 days,
10 days and 6 month air or CS exposed mice.
Plasma CORT levels Plasma 5HT levels
COG of Air ± SD COG of CS ± SD COG of Air ± SD COG of CS ± SD
3 days 9.2063.07 4.1363.41 7.0062.26 5.0363.19
10 days 12.0962.64** 12.2362.75 13.5763.55 8.5762.64
6 months 19.0663.23 1.3763.37* 1.3363.20 19.6963.50**
Data are shown as mean 6 SEM (n = 3–7 per group).
*P,0.05, **P,0.01, significance of rhythmicity as determined by CircWave analysis in air or CS exposed mice.
doi:10.1371/journal.pone.0087999.t002
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day (see Fig. 2A). In contrast, patients with COPD displayed a
significant decline in plasma CORT relative to non-smokers and
smokers. These data are in agreement with our results in mice;
that is, we observed a significant decline in the level of plasma
CORT in chronic CS exposed (COPD model) mice during the
active period (night time; see Fig. 3A). We measured comparable
effects of smoking and COPD on the level of plasma 5HT. As with
CORT, plasma 5HT was slightly elevated in smokers but was
significantly reduced in patients with COPD. In contrast with the
data from acute CS exposed mice, plasma 5HT level was slightly
greater in smokers relative to non-smokers. Interestingly, we did
observe an increase in 5HT in mice but the timing of this effect
was during the day or inactive period in mice. It is possible the
nature of the effect is the same due to the fact that CS exposure
occurred during the middle of the light phase (ZT3-9). Thus, the
acute effects of CS on serum 5HT were consistent between mice
and patients who were smokers (current/ex-smokers).
Discussion
In mammals, endogenous daily or circadian rhythms of gene
expression and physiology depend on the activity of a macromo-
lecular transcription-based oscillator. The circadian oscillator is
comprised of several complex and interactive loops of transcription
factors, kinases and co-regulators referred to as clock genes
[11,50]. The near 24 h frequency of clock gene expression defines
the period of the oscillator and drives circadian rhythms of gene
expression, cellular physiology, hormone secretion, metabolism
and behavior [50,51]. In addition to the central circadian
pacemaker located in the SCN of the basal hypothalamus,
peripheral tissues, including the lung, liver, heart and kidney are
comprised of cell-autonomous circadian oscillators [52–54]. Clock
gene expression in the lungs is altered by CS exposure in both rats
and mice [39,54–56]. Circadian or chronodisruption changes
mouse lung clock gene expression and lung mechanics [57–59]. It
is clear from our work and others that disruption of clock function
in the lungs can also have a profound influence on pulmonary
function and lung pathology [39,57–59]. However, it remains to
be determined if CS similarly affects physiological rhythms outside
the lungs, including rhythmic hormone secretion, and whether
these effects of CS also contribute to the pathophysiology of
COPD.
A bevy of evidence supports the notion that cigarette smoking is
highly associated with several neuropsychiatric disorders [16], and
Figure 2. Daily rhythms of plasma CORT and 5HT in mice exposed to sub-chronic (10 day) air or CS. Mice were exposed to CS for 10
days, and plasma samples were collected at 6-h interval for 48 h (starting at ZT12) beginning 24 h after the last exposure. Plasma levels of (A) CORT
and (B) 5HT were determined by ELISA. Gray shading indicates the dark phase (ZT12 to ZT24). Data from air- and CS-exposed mice are shown as mean
6 SEM (n= 3 mice per group). Data were fit with non-linear regression (multi-order polynomial) analyses. **P,0.01 significant compared to air-
exposed mice at ZT12; ***P,0.001 significant compared to air-exposed mice at ZT6.
doi:10.1371/journal.pone.0087999.g002
Figure 3. Daily rhythms of plasma CORT and 5HT in mice exposed to chronic (6 month) air or CS. Mice were exposed to chronic CS for 6
months and plasma samples were collected every 6-h interval (ZT0, ZT6, ZT12, ZT18 and ZT24) after 24 h of last CS exposure. Plasma levels of (A)
CORT and (B) 5HT and were determined by ELISA. Gray shading indicates the dark phase (ZT12 to ZT24). Data from air- and CS-exposed mice are
shown as mean 6 SEM (n = 3–4 mice per group). Data were analyzed with non-linear regression (multi-order polynomial) analyses. *P,0.05
significant compared to air-exposed mice at ZT0; *P,0.05 significant compared to CS-exposed mice at ZT24; ***P,0.001 significant compared to CS-
exposed mice at ZT18.
doi:10.1371/journal.pone.0087999.g003
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that the smoking related disease COPD is comorbid with
psychological distress [14,15]. It has been shown that sleep
disturbances and night-time symptoms are common in COPD
patients [10], suggesting that the function of circadian clock is
disrupted in COPD patients [10–12,60]. We have previously
determined that CS exposure significantly reduces locomotor
activity and alters molecular clock function in the brain and lungs
of mice [39]. The impacts of CS exposure on nocturnal activity are
particularly profound and suggest the development of a ‘‘depres-
sion-like’’ behavioral pattern in these mice [39]. It has been shown
that altered rhythms of plasma 5HT, CORT, and cortisol levels
and genetic polymorphisms of the clock genes and 5HT-receptors
are directly associated with depression, sleep disorders and
decreased locomotor activity [23,38,46,49,61,62]. Moreover, it
has been reported that plasma levels of 5HT and CORT are
elevated by CS exposure in mice [63,64], presumably due to
increased systemic oxidative and carbonyl stress [65]. Our aim was
to determine if the reduced locomotor activity we have observed
following CS exposure [39] had a direct relationship with the
effects if CS in the amplitude and timing of plasma 5HT and
CORT in mice. In air-exposed mice, plasma 5HT and CORT
peaked during the day and night, respectively. Chronic CS-
exposure differentially affected both 5HT and CORT levels in a
time-dependent manner. Mice exposed to CS showed an increase
in plasma 5HT in the early to middle portion of the dark phase.
Alternatively, plasma CORT levels dampened overall, with an
increase in the early light phase and a reduction during the night.
Acute CS-exposure also affected the levels of plasma 5HT and
CORT in a time-dependent manner. The level of 5HT surged
during the smoke exposure (middle of the day) and then rapidly
declined to match the level in air-exposed mice. In contrast, the
level of plasma CORT was elevated throughout the day in CS-
exposed mice. These shifted and damped rhythms of hormone
secretion were associated with repressed activity, particularly
during the dark phase [39]. These data suggest that stress induced
by CS (both chronic and acute) disrupts rhythmic secretion of
plasma CORT and 5HT and that these effects are associated with,
and perhaps mechanistically linked to the development of
depression in smokers and patients with COPD [39].
Previously, acute and short-term CS exposure in BALB/c mice
revealed conflicting influence on CORT secretion [66,67]. CS
exposure for 4 weeks significantly increased plasma CORT [66].
In an independent study of short-term CS exposure plasma
CORT levels were not affected [67]. In the present study, acute
CS-exposure mice showed plasma CORT peaked at ZT18, and in
sub-chronic CS-exposed mice the levels of CORT peaked at ZT12
Figure 4. Influence of age on daily rhythms of plasma CORT in air or CS-exposed mice. Adult mice (8–10 weeks old at start of CS exposure)
were exposed to air or CS for 3 days (young), 10 days (young) and 6 months (middle aged). Plasma levels of CORT were determined by ELISA. Gray
shading indicates the subjective dark phase (ZT12 and ZT18). Data from air- and CS-exposed mice are shown as mean 6 SEM (n = 3–7 mice per
group). Data were analyzed with non-linear regression (multi-order polynomial) analyses. +P,0.05; + + +P,0.001 significant compared to 3 days air- or
CS-exposed mice; # #P,0.01; # # #P,0.001 significant compared to 10 days air-exposed mice.
doi:10.1371/journal.pone.0087999.g004
Figure 5. Influence of age on daily rhythms of plasma 5HT in air or CS-exposed mice. Adult mice (8–10 weeks old at start of CS exposure)
were exposed to air or CS for 3 days (young), 10 days (young) and 6 months (middle aged). Plasma levels of 5HT were determined by ELISA. Gray
shading indicates the dark phase (ZT12 and ZT18). Data from air- and CS-exposed mice are shown as mean 6 SEM (n= 3–7 mice per group). Data
were analyzed with non-linear regression (multi-order polynomial) analyses. *P,0.05; **P,0.01; ***P,0.001 significant compared to 3 days air- (ZT0–
ZT18) or CS- (ZT6) exposed mice; + +P,0.01; + + +P,0.001 significant compared to 3 days air-exposed mice (ZT0–ZT18); # #P,0.01; # # #P,0.001
significant compared to 10 days air- (ZT0) or CS- (ZT6) exposed mice.
doi:10.1371/journal.pone.0087999.g005
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and remained high throughout all the ZT’s in a time-dependent
manner in response to CS. The contrasting effects of CS in the
acute (3 d), sub-chronic (10 d) and chronic (6 mo) models may be
due variation in the phase of exposure (inactive or light phase in
3 d and 6 mo vs. active phase in 10 d), concentration of CS
(TPM), main-stream/side-stream delivery method or the duration
of CS exposure (2–5 h), which may contribute to the change in the
peaking of plasma CORT and 5HT levels observed in the two
different acute and sub-chronic models of CS exposure. In another
study, the serum levels of CORT remained within the normal
range (50–300 ng/ml) when BALB/c and C57BL/6 mice were
exposed to sub-chronic CS (600 mg/L) for 5 weeks [68].
The level of 5HT remained unaltered in acute 3 days CS-
exposed mice, whereas the plasma 5HT levels peaked at ZT6 in
air-exposed mice. Similarly, levels of plasma 5HT peaked at first
ZT6 (mid-day) in sub-chronic CS-exposed mice and remain
declined in the dark period after exposure in CS-exposed mice. A
recent study has demonstrated the involvement of serotonin
metabolism in CS-induced oxidative stress in rat lung in vivo [69].
Sprague-Dawley rats were exposed to CS or air for 1 hr daily for
56 days, and 5HT levels were measured in the bronchoalveolar
lavage (BAL), lung homogenates and serum [69]. CS exposure did
not alter 5HT levels in BAL and lung homogenates. However,
serum 5HT levels and MAO-A (monoamine oxidase) activity in
the lung were significantly increased in response to CS [69]. These
findings indicate that oxidative/carbonyl stress (antioxidant GSH
depletion and protein oxidation/carbonylation) in the lung of CS
exposed rats correlates with the metabolism of 5HT by MAO-A in
the lung. This could lead to enhanced CS-mediated effects, and
may play an important role in COPD pathogenesis [69]. Another
study has shown a long-lasting effect of smoking in epigenetic
regulation of MAOB transcription [70]. Both smokers and former
smokers as compared to nonsmokers exhibit reduced methylation
of MAOB promoter, leading to active gene transcription, and
hence increased protein concentration of MAO-B as a result of
CS-induced increase in nucleic acid demethylase activity [70].
It has been shown that the detrimental metabolic effects of
combined long-term CS exposure with high-fat diet in BALB/c
mice (CS exposure: 6 days/wk, for 7 wk) did not affect plasma
CORT levels in either high-fat diet or CS exposure suggesting that
these mice had no additional stress from CS exposure during high
fat feeding [71]. Another study on long-term CS exposure in
BALB/c mice reported a higher level of CORT in pair-fed (PF)
and CS-exposed mice compared to controls [64]. The PF mice
showed a significantly higher CORT level compared to CS-
exposed mice suggesting the levels of stress imposed by exogenous
food restriction (pair feeding) was greater than the voluntary
reduction in food intake due to the anorexigenic effect of CS
exposure [64]. Recently, a long-term inhalation study with
mainstream CS in A/J mice showed a slightly more pronounced
increase in plasma CORT levels early at day 72 (,250 to 340 ng/
ml) compared towards the end of the study day 478 (,160 to
260 ng/ml) [72]. Thus, mainstream CS exposure caused elevated
plasma levels of CORT in a mouse model of chronic lung
inflammation, tumorigenesis and emphysema [72]. We have
shown that chronic CS exposure significantly increased plasma
CORT at ZT0, though it remained lower at all-time points (,100
to 170 ng/ml). This observation may be the result of the lower
concentration (,100 mg/m3 TPM) of side-stream CS exposure
used, which is minimal compared to the mainstream smoke
exposure (,150–300 mg/m3 TPM). Chronic CS exposure did not
change plasma levels of 5HT in mice. We speculate that different
methods of CS exposure, the strain of mice, concentration of
particulates (TPM) time of CS exposure (2–5 h) and the age of
mice during exposure may have an impact on the observed plasma
levels of CORT following chronic CS. These potential caveats
aside, we have for the first time shown a decrease in CORT levels
in plasma from patients with COPD compared to smokers and
non-smokers. It is not clear whether subjects who were on steroids
(smoker/patients with COPD) show any differences in the plasma
CORT levels due to lower sample size analyzed in this study.
Larger population-based studies will be needed to address the
potential influence of steroid treatments on the secretion of
circulating CORT levels in smokers and patients with COPD.
Further studies on rhythmic regulation of plasma CORT levels in
non-smokers, smokers/ex-smokers and patients with COPD may
provide better understanding on the role of altered CORT during
exacerbations and pathophysiological events in patients with
COPD.
Recent studies have shown a positive association between
plasma levels of 5HT and 5-HIAA linking severity of depression in
patients with COPD implicating their role in the development of
COPD [23,24]. A significant correlation with increased plasma
levels of 5HT in patient with COPD associated with increasing age
Figure 6. Plasma concentration of CORT and 5HT in non-smokers, smokers and patients with COPD. (A) The level of plasma CORT
increased slightly in smokers but was significantly reduced on patients with COPD relative to non-smokers and smokers (current/ex-smokers). (B)
COPD patients show lower 5HT concentration than non-smokers and smokers. The level of plasma 5HT was not affected in smokers when compared
with non-smokers. Data are shown as mean 6 SEM (n = 10–12 subjects per group). **P,0.01 significant when non-smokers were compared to
patients with COPD; # #P,0.01 significant when smokers were compared to patients with COPD.
doi:10.1371/journal.pone.0087999.g006
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has been shown in a cross-sectional study [24]. Another recent
study has demonstrated that the serotonin metabolites as possible
biomarkers for depression in patients with COPD and found
association of increased plasma 5HIAA level in depressed COPD
patients [23]. Plasma levels of 5HT among the four subject groups
(nonsmokers, smokers, non-depressed COPD, and depressed
COPD patients) were not different [23]. Our data on plasma
levels of 5HT in COPD have trend to be low compared to non-
smoker s and smokers, but are not significant which is in contrast
to the earlier report. These contrasting observations on the plasma
levels of 5HT in COPD patients may be due to other confounding
factors, such as serotonin transporter gene polymorphism and
pulmonary hypertension [73] associated with COPD patients or
other comorbidities of COPD including pulmonary artery
pressure or vascular dementia [74]. Future studies will provide
better insights on the confounding factors and their possible role in
altered plasma levels of 5HT in patients with COPD. Overall,
these data reveal that CS-induced disruption of activity, an
indirect marker of neurophysiological disease, is associated with
altered daily rhythms of plasma CORT and 5HT. Furthermore,
the disrupted rhythms of CORT and/or 5HT may be a critical
factor in the appearance of depressive behavior following CS-
exposure. These findings may have a larger impact in cigarette
smoke-induced chronic lung diseases, such as COPD and
associated comorbidities where depression is a common phenom-
enon, including addiction, predisposition to cancer and other
mental health disorders.
In conclusion, we found that CS, which we have previously
shown produces depression-like behavior, lung oxidative/carbonyl
stress and inflammation, emphysema and altered clock gene
expression in the brain and lung, also affects the timing and
amplitude of plasma 5HT and CORT secretion. The locus of
these effects remains to be determined. It is possible, given the
effects of CS on clock gene expression rhythms in the brain and
lungs, that it has similar effects on the timing of clock gene
expression in the adrenal gland, entero-chromaffin cells and the
neuroendocrine pulmonary cells releasing 5HT in the lungs. It is
also possible that CS alters the timing of 5HT release from
neurons in the raphe nuclei. It remains to be seen of the effects of
CS on mood can be directly and mechanistically linked to altered
clock function in these areas. Together, these data reveal a
significant impact of CS exposure and COPD on the timing and
amplitude of hormone secretion that could explain some of the
detrimental effects of CS on cognitive function, mood/anxiety and
sleep quality in patients with COPD.
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